New implant to stop seizures early
Part of Brain & nervous system clinical trials.
This trial tests a new implanted device that detects and stops seizures before they spread. It is for people with difficult-to-control focal seizures who have not had success with medicines.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 7 years old.
- Your seizures start in one part of the brain (focal onset seizures).
- You have tried at least two seizure medicines that didn't work well.
- You have at least 3 clear, countable seizures each month.
- You cannot be pregnant or must use reliable birth control if of childbearing age.
- You have had an MRI of your brain in the last two years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of stimulation placed under the skin to help control seizures in people with epilepsy. It is for patients whose seizures are not controlled with medication and who cannot have surgery.
This Phase 2 trial tests SPN-817 in adults whose seizures are still not well controlled despite trying multiple seizure medicines. It targets people with a specific type of brain finding called focal cortical dysplasia and looks at safety/tolerability and seizure outcomes over several weeks.
This study tests a personalized, non-invasive brain stimulation method called tDCS for people with drug-resistant epilepsy that starts in one part of the brain. It aims to reduce seizures in those who cannot have surgery or have not been helped by surgery.
This trial tests a new device to help diagnose epilepsy in people whose previous EEG brain monitoring did not give clear answers. If you have drug-resistant epilepsy with at least one seizure a month on average, this study may help find better treatment options.
This trial tests a personalized brain stimulation method (transcranial electrical stimulation) to reduce seizures in children with hard-to-control partial epilepsy. It aims to find the best stimulation spot and settings for each patient by using advanced brain scans.
This study tests how well a specific brain-recording device works during a procedure used to map seizure origins in people with drug-resistant, disabling focal epilepsy. It may help doctors plan treatment by improving how well they can localize the seizure focus before possible surgery.
Hear when a new Epilepsy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.